Formulation and evaluation of different hydrogels loaded with Florite®-based etodolac adsorbate: In vitro and in vivo correlation

Inoue, 2011, The enantiomers of etodolac, a racemic anti-inflammatory agent, play different roles in efficacy and gastrointestinal safety, Biol. Pharm. Bull., 34, 655, 10.1248/bpb.34.655 Serajuddin, 1999, Solid dispersion of poorly water‐soluble drugs: early promises, subsequent problems, and recent breakthroughs, J. Pharmaceut. Sci., 88, 1058, 10.1021/js980403l Shilakari Asthana, 2016, Etodolac containing topical niosomal gel: formulation development and evaluation, J. Drug Deliv., 1, 10.1155/2016/9324567 Banker, 2002 Sabale, 2012, Formulation and evaluation of microemulsion-based hydrogel for topical delivery, Int. J.Pharmaceut. Invest., 2, 140, 10.4103/2230-973X.104397 Pal, 2009, Polymeric hydrogels: characterization and biomedical applications, Des. Monomers Polym., 12, 197, 10.1163/156855509X436030 Arakelova, 2013 Ahmed, 2015, Hydrogel: preparation, characterization, and applications: a review, J. Adv. Res., 6, 105, 10.1016/j.jare.2013.07.006 Charoenchaitrakool, 2000, Micronization by rapid expansion of supercritical solutions to enhance the dissolution rates of poorly water-soluble pharmaceuticals, J. Ind. Eng.Chem. Res., 39, 4794, 10.1021/ie000151a Komala, 2015, Competence of raloxifene hydrochloride loaded liquisolid compacts for improved dissolution and intestinal permeation, J. Drug Deliv. Sci. Technol., 30, 232, 10.1016/j.jddst.2015.10.020 Wempe, 2008, Pharmacokinetics of raloxifene in male Wistar–Hannover rats: influence of complexation with hydroxybutenyl-beta-cyclodextrin, Int. J. Pharm., 346, 25, 10.1016/j.ijpharm.2007.06.002 Ravi, 2014, Lipid nanoparticles for oral delivery of raloxifene: optimization, stability, in vivo evaluation and uptake mechanism, Eur. J. Pharm. Biopharm., 87, 114, 10.1016/j.ejpb.2013.12.015 Elsheikh, 2012, Nanoemulsion liquid preconcentrates for raloxifene hydrochloride: optimization and in vivo appraisal, Int. J. Nanomed., 7, 3787 Zayed, 2014, Dissolution rate enhancement of ketoprofen by surface solid dispersion with colloidal silicon dioxide, Unique. J. Pharmaceut. Biol. Chem., 1, 33 Law, 1990, Improving dissolution rates of griseofulivin by deposition on disintegrants, Drug Dev. Ind. Pharm., 16, 137, 10.3109/03639049009115990 Law, 1990, Improving dissolution rates of griseofulivin by deposition on disintegrants, Drug Dev. Ind. Pharm., 16, 137, 10.3109/03639049009115990 Ismail, 2004, Preparation and evaluation of naproxen adsorbate as an attempt to improve drug dissolution characteristics, Bull. Pharmaceut.Sci.Assiut, 27, 53, 10.21608/bfsa.2004.65408 Chella, 2012, Use of the liquisolid compact technique for improvement of the dissolution rate of valsartan, Acta Pharm. Sin. B, 2, 502, 10.1016/j.apsb.2012.07.005 Srikanth, 2013, Dissolution rate enhancement of bicalutamide by adsorption process, Afr. J.Pharm. Pharmacol, 7, 1357, 10.5897/AJPP10.073 Putra, 2009, Performance of activated carbon and bentonite for adsorption of amoxicillin from wastewater: mechanisms, isotherms and kinetics, J. Water .Res., 43, 2419, 10.1016/j.watres.2009.02.039 Qian, 2012, Application of mesoporous silicon dioxide and silicate in oral amorphous drug delivery systems, J. Pharmaceut. Sci., 101, 444, 10.1002/jps.22779 Mahajan, 2018, Solid dispersion adsorbate technique for improved dissolution and flow properties of lurasidone hydrochloride: characterization using 32 factorial design, J.Drug.Dev. Ind. Pharm., 44, 463, 10.1080/03639045.2017.1397687 Ibrahim, 2010, Formulation and evaluation of ketorolac tromethamine-Eudragit solid dispersions of potential sustained-release properties, STP Pharma Prat., 20, 189 Ismail, 2009, Enhancement of solubility and dissolution of nimesulide using solubilization, solid dispersion and complexation techniques, Bull. Pharmaceut.Sci.Assiut, 32, 321, 10.21608/bfsa.2009.63509 Kumar, 2006, Preparation, characterization and in vitro dissolution studies of solid dispersion of Meloxicam with PEG 60001, Yakugaku Zasshi, 126, 657, 10.1248/yakushi.126.657 Coviello, 2007, Polysaccharide hydrogels for modified release formulations, J. Contr. Release, 119, 5, 10.1016/j.jconrel.2007.01.004 Tas, 2003, In vitro release studies of chlorpheniramine maleate from gels prepared by different cellulose derivatives, Il Farmaco, 58, 605, 10.1016/S0014-827X(03)00080-6 Islam, 2004, Rheological characterization of topical carbomer gels neutralized to different pH, J. Pharmaceut. Res., 21, 1192, 10.1023/B:PHAM.0000033006.11619.07 Yapar, 2013, Design and in vivo evaluation of emulgel formulations including green tea extract and rose oil, Acta Pharm., 63, 531, 10.2478/acph-2013-0037 Siewert, 2003, FIP/AAPS guidelines to dissolution/in vitro release testing of novel/special dosage forms, AAPS PharmSciTech, 4, 43, 10.1208/pt040107 Winter, 1962, Carrageenin-induced edema in hind paw of the rat as an assay for antiinflammatory drugs, Exp. Biol. Med., 111, 544, 10.3181/00379727-111-27849 Habiba, 2014, Different topical formulations of ketorolac tromethamine for anti-inflammatory application and clinical efficacy, Digest J.Nanomater.Biostructures, 9, 705 Winter, 1963, Anti-inflammatory and antipyretic activities of indo-methacin, 1-(p-chlorobenzoyl)-5-methoxy-2-methyl-indole-3-acetic acid, J. Pharmacol. Exp. Therapeut., 141, 369 Draize, 1944, Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes, J. Pharmacol. Exp. Therapeut., 82, 377 Dwivedi, 2010, Quantum chemical study of etodolac (lodine), Der Pharma Chem., 2, 58 Florey, 1981 Abdelbary, 2013, Influence of various polymers on the improvement of etodolac solubility and dissolution rate via. Solid dispersion technique, Inven. Impact Pharm. Tech., 2013, 1 Ismail, 2009, Enhancement of solubility and dissolution of nimesulide using solubilization, solid dispersion and complexation techniques, Bull. Pharmaceut.Sci.Assiut, 32, 321, 10.21608/bfsa.2009.63509 Terinte, 2011, Overview on native cellulose and microcrystalline cellulose I structure studied by X-ray diffraction (WAXD): comparison between measurement techniques, Lenzinger Berichte, 89, 118 Qian, 2010, Drug–polymer solubility and miscibility: stability consideration and practical challenges in amorphous solid dispersion development, J. Pharmaceut. Sci., 99, 2941, 10.1002/jps.22074 Kawano, 2021, Solubility enhancement of Ibuprofen by adsorption onto spherical porous calcium silicate, Pharmaceutics, 13, 767, 10.3390/pharmaceutics13060767 Planinšek, 2011, Carvedilol dissolution improvement by preparation of solid dispersions with porous silica, Int. J. Pharm., 406, 41, 10.1016/j.ijpharm.2010.12.035 Ali, 1992, Molecular behavior of Flufenamic acid in physical and ground mixtures with florite, Chem. Pharm. Bull., 40, 1289, 10.1248/cpb.40.1289 Ali, 1997, Enhancement of dissolution rate of carbamazepine: In vitro studies, Chem. Pharm. Bull. Pharm. Sci., 20, 1 Cleary, 2019, 203 Yapar, 2013, Design and in vivo evaluation of emulgel formulations including green tea extract and rose oil, Acta Pharm., 63, 531, 10.2478/acph-2013-0037 Saroha, 2013, Transdermal gels- an alternative vehicle for drug delivery, Int. J. Pharmaceut. Chem. Biol. Sci., 3 Kinoshita, 2002, Improvement of solubility and oral bioavailability of a poorly water-soluble drug, TAS-301, by its melt-adsorption on a porous calcium silicate, J Pharm Sci, 91, 362, 10.1002/jps.10026 Mehrabifar, 2017, Significany increasing of gastrointestinal dissolution of aceclofenac via Florite, MedBioTech J, 1, 9 Saarai, 2012, On the characterization of sodium alginate/gelatine‐based hydrogels for wound dressing, J. Appl. Polym. Sci., 126, E79, 10.1002/app.36590 Ritger, 1987, A simple equation for description of solute release II. Fickian and anomalous release from swellable devices, J. Contr. Release, 5, 37, 10.1016/0168-3659(87)90035-6 Auda, 2015, In-vitro release and in-vivo performance of tolmetin from different topical gel formulations, J.Pharmaceut.Invest., 45, 311, 10.1007/s40005-015-0174-3 Winter, 1962, Carrageenin-induced edema in hind paw of the rat as an assay for antiinflammatory drugs, Exp. Biol. Med., 111, 544, 10.3181/00379727-111-27849